CVRx, Inc. (CVRX) vs Sera Prognostics, Inc. (SERA)
CVRx, Inc. and Sera Prognostics, Inc. are both Medical Devices companies. Sera Prognostics, Inc. is the larger, with a market value of $83.2M against $67.4M — 1.2× the size. CVRx, Inc. grew revenue faster over the last twelve months: 12.0% against −35.2%. CVRx, Inc. has the higher net margin (−84.9% vs −47,475.7%) and the lower return on invested capital (−218.1% vs −180.2%). Across the 18 metrics below, CVRx, Inc. leads on 10 and Sera Prognostics, Inc. on 8.
Valuation
Profitability
| Metric | CVRX | SERA | Medical Devices median |
|---|---|---|---|
| Gross margin | 86.92% | (150.00%) | 56.01% |
| Operating margin | (79.49%) | (53,282.86%) | (15.03%) |
| Net margin | (84.93%) | (47,475.71%) | (20.40%) |
| Free cash flow margin | (67.09%) | (40,760.00%) | (7.24%) |
| Return on equity | (133.44%) | (45.03%) | (15.32%) |
| Return on assets | (49.06%) | (33.47%) | (19.72%) |
| Return on invested capital | (218.09%) | (180.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack